Patient-friendly real-time remote monitoring system receives FDA clearance

Corsano Health has received FDA clearance for their CardioWatch System, a multi-sensor bracelet for real-time continuous remote health monitoring. The system, already certified in Europe, collects vital signs data such as pulse rate and blood pressure, transmitting it to a secure health cloud for analysis. The FDA clearance marks a milestone for Corsano in providing continuous patient monitoring. Remote patient monitoring (RPM) is driving the growth of the global patient monitoring market. Integration remains a challenge for developers, but the CardioWatch System includes an API and SDK for integration with third-party devices. The system aims to improve patient outcomes and provide a better healthcare experience.

Source link

error: Content is protected !!